Symptom-agnostic endpoints in tuberculosis vaccine efficacy trials

IF 22.5 1区医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Lancet Global Health Pub Date : 2026-10-01 DOI:10.1016/j.langlo.2026.104079

Morten Ruhwald,Alemnew F Dagnew,Gavin Churchyard,Adam Penn-Nicholson,Puneet Dewan,Alberto L Garcia-Basteiro,Emily B Wong,Willem A Hanekom,Mark Hatherill,Reinout van Crevel,Saskia den Boon,Patricia Hall-Eidson,Rein M G J Houben,Ann M Ginsberg,Frank Cobelens,Katherine C Horton,Richard G White

引用次数: 0

查看原文本刊更多论文

结核疫苗疗效试验的症状不可知终点

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Lancet Global Health PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

44.10

自引率

1.20%

发文量

763

审稿时长

10 weeks

期刊介绍： The Lancet Global Health is an online publication that releases monthly open access (subscription-free) issues.Each issue includes original research, commentary, and correspondence.In addition to this, the publication also provides regular blog posts. The main focus of The Lancet Global Health is on disadvantaged populations, which can include both entire economic regions and marginalized groups within prosperous nations.The publication prefers to cover topics related to reproductive, maternal, neonatal, child, and adolescent health; infectious diseases (including neglected tropical diseases); non-communicable diseases; mental health; the global health workforce; health systems; surgery; and health policy.